Mycoplasma infections in humans

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F13%3A10194320" target="_blank" >RIV/00179906:_____/13:10194320 - isvavai.cz</a>
Alternative codes found
RIV/60162694:G44__/13:43875011 RIV/00216208:11150/13:10194320 RIV/00216275:25310/13:39896714
Result on the web
<a href="http://mmsl.cz/viCMS/soubory/pdf/MMSL_2013_4_1_WWW.pdf" target="_blank" >http://mmsl.cz/viCMS/soubory/pdf/MMSL_2013_4_1_WWW.pdf</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Mycoplasma infections in humans
Original language description
Several Mycoplasma species are important causative agents of various infections of mucosal surfaces in humans, especially in the urogenital or respiratory tracts. Pathogenetic mechanisms of mycoplasmas are intensively studied. The "gold" standard of mycoplasma detection in cultivation, which is very difficult and time-consuming. The other options for identifying mycoplasmas include direct antigen detection or molecular-biology methods, such as polymerase chain reaction, DNA-hybridization and sequencing.Mycoplasmas are naturally resistant to beta-lactam antibiotics because of lack of cell wall. Tetracyclines or fluoroquinolones are regarded as the first choice in the treatment of mycoplasma infections. Several reports have documented resistance of mycoplasmas to macrolides worldwide. This report summarizes our current knowledge of laboratory diagnosis and treatment of mycoplasma infections.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EE - Microbiology, virology
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)